Novel First-in-Class Drug Discovery Approach is Breaking New Ground in Anti-Cancer Therapeutics
ATP-hydrolyzing enzymes like protein kinases are major drug targets for oncology. Drugs that inhibit these enzymes typically engage their ATP-binding (active) sites to inhibit catalysis. However, these active sites are …